Moderna Inc (MRNA)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 1,541,000 | 1,731,000 | 3,458,000 | 4,033,000 | 4,693,000 | 5,682,000 | 4,541,000 | 5,191,000 | 5,416,000 | 4,450,000 | 4,072,000 | 3,441,000 | 2,617,000 | 1,672,933 | 1,294,933 | 696,933 | 618,933 | 728,954 | 504,591 | 480,896 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $1,541,000K ÷ $—K
= —
Based on the provided data, the payables turnover ratio for Moderna Inc is not available for the periods mentioned. The payables turnover ratio measures how efficiently a company is managing its accounts payable by evaluating how many times a company pays off its average accounts payable balance in a given period.
Since the payables turnover ratio is not provided for any of the specified dates, it is not possible to analyze how quickly Moderna Inc is paying off its suppliers or how effectively it is managing its accounts payable during those periods.
It is essential to have data on accounts payable and cost of goods sold to calculate the payables turnover ratio accurately. Without this information, a comprehensive analysis of Moderna Inc's payables turnover ratio and its implications for the company's financial performance cannot be conducted.
Peer comparison
Dec 31, 2024